PMID- 22023385 OWN - NLM STAT- MEDLINE DCOM- 20120402 LR - 20131121 IS - 1520-5010 (Electronic) IS - 0893-228X (Linking) VI - 24 IP - 11 DP - 2011 Nov 21 TI - Relating skin sensitizing potency to chemical reactivity: reactive Michael acceptors inhibit NF-kappaB signaling and are less sensitizing than S(N)Ar- and S(N)2- reactive chemicals. PG - 2018-27 LID - 10.1021/tx2003678 [doi] AB - The skin sensitization potency of chemicals is partly related to their reactivity to proteins. This can be quantified as the rate constant of the reaction with a model peptide, and a kinetic profiling approach to determine rate constants was previously proposed. A linear relationship between the skin sensitization potency in the local lymph node assay (LLNA) and the rate constant for Michael acceptors was reported, characterized by a relatively flat regression line. Thus, a 10-fold increase of reactivity correlates to an increase of the sensitization potential of only 1.7-fold. Here, we first validate this model by repeating previous data and testing additional Michael acceptors and prove that the model is both reproducible and robust to the addition of new data. Chemicals of different mechanistic applicability domains, namely, S(N)Ar- and S(N)2-reactive sensitizers, were then tested with the same kinetic profiling approach. A linear relationship between sensitization potency in the LLNA and rate constants was also found, yet with a much steeper slope, i.e., for S(N)Ar- and S(N)2-reactive sensitizers, increasing reactivity correlates to a much stronger increase in sensitization potency. On the basis of the well-known inhibitory activity of some Michael acceptors on IKK kinase, it was hypothesized that the difference in the slopes is due to the specific anti-inflammatory potential of Michael acceptor chemicals. Therefore, all chemicals were tested for anti-inflammatory activity in a reporter gene assay for the inhibition of NF-kappaB activation. Increasingly reactive Michael acceptors have increasing anti-inflammatory potential in this assay, whereas no such biological activity was detected for the S(N)Ar and S(N)2 reactive sensitizers. Thus, the increasing reactivity of Michael acceptors confers both anti-inflammatory and skin sensitizing/pro-inflammatory potential, which may partially neutralize each other. This may be the reason for the relatively weak relationship between the potency in the LLNA and the rate constant of this particular group of chemicals. FAU - Natsch, Andreas AU - Natsch A AD - Givaudan Schweiz AG, Duebendorf, Switzerland. andreas.natsch@givaudan.com FAU - Haupt, Tina AU - Haupt T FAU - Laue, Heike AU - Laue H LA - eng PT - Journal Article DEP - 20111107 PL - United States TA - Chem Res Toxicol JT - Chemical research in toxicology JID - 8807448 RN - 0 (Lactones) RN - 0 (NF-kappa B) RN - 0 (Peptides) RN - 0 (Plant Extracts) RN - 0 (Sesquiterpenes) RN - EC 2.7.11.10 (I-kappa B Kinase) RN - Z4ZG7O5SZ9 (Picryl Chloride) SB - IM MH - Animals MH - Arnica/*chemistry MH - Dermatitis, Allergic Contact/immunology/*metabolism MH - Humans MH - I-kappa B Kinase/immunology/metabolism MH - Immunization MH - Kinetics MH - Lactones/chemistry/immunology/*metabolism MH - Local Lymph Node Assay MH - Mice MH - NF-kappa B/immunology/metabolism MH - Peptides/chemistry/*metabolism MH - Picryl Chloride/chemistry/immunology/*metabolism MH - Plant Extracts/chemistry MH - Quantitative Structure-Activity Relationship MH - Sesquiterpenes/chemistry/immunology/*metabolism MH - Signal Transduction/immunology MH - Skin/immunology/*metabolism EDAT- 2011/10/26 06:00 MHDA- 2012/04/03 06:00 CRDT- 2011/10/26 06:00 PHST- 2011/10/26 06:00 [entrez] PHST- 2011/10/26 06:00 [pubmed] PHST- 2012/04/03 06:00 [medline] AID - 10.1021/tx2003678 [doi] PST - ppublish SO - Chem Res Toxicol. 2011 Nov 21;24(11):2018-27. doi: 10.1021/tx2003678. Epub 2011 Nov 7.